Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Immunocore Holdings (IMCR) Shares Outstanding (Diluted Average): 2023-2024

Historic Shares Outstanding (Diluted Average) for Immunocore Holdings (IMCR) over the last 2 years, with Dec 2024 value amounting to $50.0 million.

  • Immunocore Holdings' Shares Outstanding (Diluted Average) fell 4.55% to $50.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $50.4 million, marking a year-over-year decrease of 4.55%. This contributed to the annual value of $50.0 million for FY2024, which is 2.25% up from last year.
  • As of FY2024, Immunocore Holdings' Shares Outstanding (Diluted Average) stood at $50.0 million, which was up 2.25% from $48.9 million recorded in FY2023.
  • Immunocore Holdings' 5-year Shares Outstanding (Diluted Average) high stood at $50.0 million for FY2024, and its period low was $48.9 million during FY2023.
  • Its 2-year average for Shares Outstanding (Diluted Average) is $49.4 million, with a median of $49.4 million in 2023.
  • Data for Immunocore Holdings' Shares Outstanding (Diluted Average) shows a peak YoY grew of 2.25% (in 2024) over the last 5 years.
  • Yearly analysis of 2 years shows Immunocore Holdings' Shares Outstanding (Diluted Average) stood at $48.9 million in 2023, then climbed by 2.25% to $50.0 million in 2024.